학술논문
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
Document Type
Article
Author
Merola, Joseph F; Landewé, Robert; McInnes, Iain B ; Mease, Philip J; Ritchlin, Christopher T; Tanaka, Yoshiya; Asahina, Akihiko; Behrens, Frank; Gladman, Dafna D; Gossec, Laure; Gottlieb, Alice B; Thaçi, Diamant; Warren, Richard B; Ink, Barbara; Assudani, Deepak; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Coates, Laura C
Source
In The Lancet 7-13 January 2023 401(10370):38-48
Subject
Language
ISSN
0140-6736